Team
–
Rounds
–
Total raised
–
About
Coherence Neuro is developing neurotechnology, including the CIPHER System and the SOMA brain-computer interface, to monitor cancer and deliver therapeutic stimulation. Its devices are investigational and not approved by the FDA or TGA; a first-in-human study started in Melbourne in 2026. It is based in San Francisco and backed by Armenia-based SmartGate VC.